Post-effective amendment to a registration statement that is not immediately effective upon filing


$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (70,526) $ (25,643)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,294 4,640
Foreign exchange (gain) loss on long-term debt (14) 26
Gain on extinguishment of debt (2,096)
Change in fair value of warrants and derivatives (7,940)
Share-based compensation expense 10,577 2,643
Loss on disposal of property, plant and equipment 22 3
Bad debt expense 289 5
Total adjustments 5,132 7,317
Changes in operating assets and liabilities:    
Decrease (increase) in accounts receivable 12,352 (30,345)
(Increase) decrease in inventory (5,198) 5,123
Decrease in prepaid expenses and other current assets (6,547) (517)
Increase in other operating assets (105) (380)
(Decrease) increase in accounts payable (10,790) 12,012
Increase in deferred revenue (4,619) (2,514)
Increase in other accrued expenses 4,429 5,104
Increase in other long-term liabilities 616 5,889
Increase in accrued interest on long-term debt 8,571 3,587
Net cash used in operating activities (66,685) (20,367)
Cash flows from investing activities:    
Purchase of property, plant and equipment (6,033) (2,226)
Net cash used in investing activities (6,033) (2,226)
Cash flows from financing activities:    
Repayments of line of credit, net (1,993)
Borrowings under senior term loan 6,005
Borrowings under other long-term debt 2,073
Proceeds from the Business Combination, issuance of convertible debt and PIPE financing, net of issuance costs paid 115,501
Proceeds from the exercise of stock options 1,074
Proceeds from the sale of Series G stock, net 21,913
Proceeds from the sale of Series H stock, net 505 8,074
Proceeds from the issuance of Series H warrants 142 2,126
Net cash provided by financing activities 117,222 38,198
Net increase in cash, cash equivalents and restricted cash 44,504 15,605
Cash, cash equivalents and restricted cash, beginning of year 18,618 3,013
Cash, cash equivalents and restricted cash, end of year 63,122 18,618
Supplemental disclosures of cash flow information    
Cash paid for interest (12,809) (6,363)
Cash paid for income taxes, net of cash received from R&D tax credit refunds (73)
Cash received from R&D tax credit refunds, net of cash paid for income taxes 241
Operating cash flows from operating leases (3,006) (2,857)
Lease liability obtained in exchange for obtaining right-of-use assets 796
Supplemental disclosure of non-cash financing activities:    
Reclassification of redeemable convertible preferred stock warrants to additional paid-in capital 10,291
Non-cash net liabilities assumed from business combination 38
Issuance of preferred stock upon conversion of debt 23,571
Conversion of debt to preferred stock (23,571)
Assignment of line of credit to new lender under Senior term loan $ 32,940